Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Roflumilast in Non-cystic Fibrosis Bronchiectasis
NCT04122547Phase 3Completed
- Sponsor
- Prince of Songkla University
- Start
- Jan 2015
- Primary completion
- Dec 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Non-cystic fibrosis bronchiectasis (NCFB) comparing Roflumilast with Placebo (2 arms). Primary endpoint: Acute deterioration of bronchiectasis symptoms at 6 months. Started Jan 2015; status: completed.
02
Drugs
roflumilast
03
Conditions
Non-cystic fibrosis bronchiectasis (NCFB)
Beyond the preview
Go deeper on NCT04122547.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04122547.